Hep B,C & ICT TB at Dr. Essa Lab

Understanding the Hep B,C & ICT TB Panel at Dr. Essa Lab

The Hep B,C & ICT TB panel is a specialized, comprehensive rapid screening blood test designed to detect three of the most prevalent and clinically significant infectious diseases in Pakistan: Hepatitis B, Hepatitis C, and Tuberculosis (TB). Dr. Essa Laboratory & Diagnostic Centre, a pioneer in diagnostic medicine in Karachi and across Pakistan since 1987, offers this combined panel to provide rapid, highly reliable qualitative screening. This panel is particularly crucial in regions with high endemicity, serving as a cornerstone for pre-employment clearances, visa medical examinations, pre-surgical screenings, and routine health evaluations.

The panel utilizes advanced immunochromatographic technology to identify specific viral antigens and host antibodies in a patient’s blood sample. By combining these three critical assays into a single draw, Dr. Essa Lab ensures a streamlined diagnostic process that minimizes patient discomfort and optimizes clinical turnaround time. Understanding the individual components of this panel is essential for appreciating its clinical utility:

• Hepatitis B (HBsAg): This component screens for the Hepatitis B Surface Antigen, which is the earliest reliable serological marker for active Hepatitis B virus (HBV) infection. Its presence indicates that the patient is infectious, whether the infection is acute or chronic.
• Hepatitis C (Anti-HCV): This test detects antibodies produced by the immune system in response to the Hepatitis C virus (HCV). A reactive result indicates exposure to the virus, necessitating further molecular confirmation.
• ICT TB (Immunochromatographic Test for Tuberculosis): This rapid assay detects specific antibodies (typically IgG, IgM, and sometimes IgA) directed against recombinant antigens of Mycobacterium tuberculosis. While molecular tests like GeneXpert remain the gold standard for active pulmonary TB diagnosis, the ICT TB test serves as a valuable rapid screening aid, especially in resource-limited settings or as part of a multi-system diagnostic workup.

By integrating these three assays, the Hep B,C & ICT TB panel at Dr. Essa Lab provides clinicians with a rapid, multi-pathogen assessment. This allows for early intervention, appropriate isolation protocols if necessary, and timely referral to hepatology or pulmonology specialists, ultimately improving patient outcomes and public health safety.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of your Hep B,C & ICT TB panel results at Dr. Essa Lab, patients are advised to follow these preparation guidelines:

• Fasting Requirements: Strict fasting is generally not required for this serological panel. You may eat and drink normally before the test. However, it is highly recommended to avoid excessively fatty meals immediately before sample collection, as high levels of lipids in the blood (lipemia) can sometimes interfere with optical immunochromatographic readings.
• Hydration: Drink plenty of water before your appointment. Adequate hydration ensures your veins are well-filled, making the venipuncture process smoother and more comfortable.
• Medication Disclosure: Inform the phlebotomist and your prescribing physician of all medications, immunosuppressants, or biological therapies you are currently taking. Immunosuppressive drugs can potentially suppress antibody production, which may lead to false-negative results in the antibody-based components of the panel (Anti-HCV and ICT TB).
• Clothing: Wear a comfortable, loose-fitting shirt or a garment with sleeves that can be easily rolled up above the elbow to allow clear access to the venipuncture site.

During the Procedure

The sample collection process at Dr. Essa Lab is performed by highly trained, certified phlebotomists adhering to strict international biosafety standards. The entire procedure is quick, typically taking less than five minutes:

• Sanitization and Setup: The phlebotomist will verify your identity, explain the procedure, and sanitize their hands. They will prepare a sterile, single-use vacuum tube system and needle.
• Vein Selection: A tourniquet is applied to your upper arm to make the veins in your antecubital fossa (inner elbow) more visible and palpable. The selected site is thoroughly cleansed with an antiseptic alcohol swab and allowed to air dry.
• Venipuncture: The needle is gently inserted into the vein. You may feel a brief, minor pinch. Blood is drawn into a gold-top (serum separator) or red-top vacuum tube.
• Post-Collection Care: Once the required volume of blood is collected, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball to prevent bruising. A small adhesive bandage is then applied.
• Safety and Comfort: All materials used are strictly single-use and disposed of in biohazard containers immediately. Patients are advised to keep the bandage on for at least 1 to 2 hours and avoid heavy lifting with that arm for the rest of the day.

When is a Hep B,C & ICT TB Performed?

Pre-Employment and Visa Medical Screenings

Many local and international employers, particularly in healthcare, hospitality, and heavy industry, require comprehensive infectious disease screening before hiring. Similarly, several countries require mandatory screening for Hepatitis B, Hepatitis C, and Tuberculosis as part of the visa medical clearance process for immigration, work, or study. This panel provides a rapid, cost-effective way to satisfy these regulatory and occupational health requirements, ensuring a safe working environment and preventing cross-border transmission of chronic infections.

Pre-Surgical and Pre-Procedural Evaluations

Prior to undergoing elective or emergency surgical procedures, dental surgeries, or invasive diagnostic interventions, surgeons and anesthesiologists frequently request the Hep B,C & ICT TB panel. Identifying a patient’s infectious status is vital for implementing appropriate infection control measures in the operating theater, protecting healthcare workers from accidental needle-stick injuries, and tailoring post-operative patient care, particularly if liver function or respiratory health is compromised.

Evaluation of Unexplained Fatigue and Jaundice

Physicians often order this panel when a patient presents with constitutional symptoms such as persistent, unexplained fatigue, low-grade fever, loss of appetite, nausea, or localized symptoms like right upper quadrant abdominal pain and jaundice (yellowing of the skin and eyes). These clinical signs are classic indicators of hepatic inflammation, which may be caused by chronic Hepatitis B or C infections. Simultaneously screening for Tuberculosis helps rule out systemic infectious etiologies that present with overlapping constitutional symptoms.

Investigation of Chronic Cough and Night Sweats

Tuberculosis remains a major public health challenge in Pakistan. When a patient presents with a persistent productive cough lasting more than two to three weeks, hemoptysis (coughing up blood), unexplained weight loss, and drenching night sweats, a physician must rapidly investigate for TB. Including Hepatitis B and C in this diagnostic workup is highly beneficial, as co-infections can significantly alter the patient’s immune response, liver tolerance to anti-tuberculosis therapy (which is hepatotoxic), and overall clinical management.

Screening for High-Risk Exposure or Healthcare Workers

Healthcare professionals, laboratory technicians, individuals undergoing renal dialysis, patients receiving frequent blood transfusions, and individuals with a history of exposure to unsterile medical or dental equipment are at an elevated risk for bloodborne pathogens. Regular screening with this panel allows for early detection of subclinical or asymptomatic infections, enabling prompt therapeutic intervention before significant organ damage or transmission to others occurs.

What Does a Hep B,C & ICT TB Detect?

The Hep B,C & ICT TB panel is designed to detect specific immunological and viral markers in the blood. A comprehensive analysis of this panel can identify several distinct clinical states and findings:

• Active Hepatitis B Infection: Detected via a reactive HBsAg result, indicating the presence of the virus in the blood.
• Chronic Hepatitis B Carrier State: Indicated by persistent HBsAg reactivity over six months, suggesting chronic infection.
• Absence of Hepatitis B Infection: A non-reactive HBsAg result, indicating no active infection (though it does not rule out immunity from vaccination or resolved infection).
• Exposure to Hepatitis C Virus: Detected via a reactive Anti-HCV antibody result, indicating that the patient’s immune system has encountered the virus.
• Active Hepatitis C Infection (Potential): A reactive Anti-HCV test suggests active infection, which must be confirmed using highly sensitive HCV RNA PCR testing.
• Resolved Hepatitis C Infection: A reactive Anti-HCV result can persist even after the patient has cleared the virus naturally or through successful antiviral therapy.
• Absence of Hepatitis C Exposure: A non-reactive Anti-HCV result, indicating no detectable antibodies against the virus.
• Exposure to Mycobacterium tuberculosis: Detected via a reactive ICT TB result, indicating the presence of circulating antibodies against TB antigens.
• Active Pulmonary Tuberculosis (Potential): A reactive ICT TB in a symptomatic patient strongly suggests active disease, requiring confirmation via sputum smear, culture, or GeneXpert.
• Active Extrapulmonary Tuberculosis (Potential): Antibody detection can sometimes aid in suggesting extrapulmonary TB where sputum samples are unobtainable.
• Latent Tuberculosis Infection (LTBI): The test may detect antibodies in individuals with latent infection who do not exhibit active symptoms.
• Absence of Detectable TB Antibodies: A non-reactive ICT TB result, indicating no serological evidence of TB exposure (though false negatives can occur in early or severe disease).
• Triple Co-infection: Rare but clinically severe cases where HBsAg, Anti-HCV, and ICT TB are all reactive, requiring highly specialized, multi-disciplinary medical management.
• Double Co-infection (HBV and HCV): Simultaneous reactivity for HBsAg and Anti-HCV, indicating dual viral hepatitis infection.
• Double Co-infection (HBV and TB): Simultaneous reactivity for HBsAg and ICT TB, requiring careful monitoring of liver enzymes during TB treatment.
• Double Co-infection (HCV and TB): Simultaneous reactivity for Anti-HCV and ICT TB, necessitating coordinated antiviral and antibacterial therapies.
• Atypical Mycobacterial Cross-Reactivity: Potential weak reactivity in the ICT TB component due to exposure to non-tuberculous environmental mycobacteria.
• Immunosuppression-Induced False Negatives: Non-reactive antibody results (Anti-HCV or ICT TB) in patients with advanced HIV or those on chemotherapy, despite active infection.
• Early Window Period for Hepatitis B: A non-reactive HBsAg result if the blood draw occurs within the first few weeks of exposure before antigen levels rise.
• Early Window Period for Hepatitis C: A non-reactive Anti-HCV result if the test is performed before the immune system has produced detectable antibody levels (typically 8-11 weeks).
• Early Window Period for Tuberculosis: A non-reactive ICT TB result in the very early stages of infection before a measurable humoral immune response is mounted.
• Invalid Test Run: Indicated by the absence of a control line on any of the individual immunochromatographic test strips, requiring an immediate repeat of the assay.
• Specimen Interference (Hemolysis): Red blood cell rupture during collection that may obscure or interfere with the visual or optical reading of the test strips.
• Specimen Interference (Lipemia): High lipid content in the serum that can cause physical interference with the lateral flow of the sample across the membrane.
• Specimen Interference (Icterus): Extremely high bilirubin levels that can color the serum and potentially affect the visual interpretation of rapid test bands.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is committed to providing rapid and highly accurate diagnostic reporting. Because the Hep B,C & ICT TB panel utilizes rapid immunochromatographic technology, the laboratory processing time is highly optimized. In most cases, reports are finalized and verified by a consultant pathologist within the same day of sample collection, typically within 6 to 12 hours.

Patients can access their diagnostic reports through multiple convenient channels provided by Dr. Essa Lab:

• Online Web Portal: Patients can securely log in to the official Dr. Essa Lab website using the unique patient ID and password printed on their receipt to view and download their PDF reports.
• Mobile Application: The Dr. Essa Lab mobile app allows patients to track their test status, view historical reports, and download current results directly to their smartphones.
• SMS Notifications: An automated SMS is sent to the patient’s registered mobile number as soon as the report is finalized, containing a direct link to download the digital report.
• Physical Collection: Patients or their authorized representatives can collect printed, signed reports from any of the numerous Dr. Essa Lab collection centers across Karachi and other cities.

Hep B,C & ICT TB Findings Overview

The following table outlines the parameters evaluated in the Hep B,C & ICT TB panel, along with their clinical interpretation:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatitis B Surface Antigen (HBsAg)	Non-Reactive (Negative)	Reactive (Positive) – Indicates active acute or chronic Hepatitis B infection.
Anti-Hepatitis C Virus (Anti-HCV) Antibodies	Non-Reactive (Negative)	Reactive (Positive) – Indicates exposure to Hepatitis C; requires confirmatory PCR.
ICT Tuberculosis IgG Antibodies	Non-Reactive (Negative)	Reactive (Positive) – Suggests past exposure, latent, or active Tuberculosis infection.
ICT Tuberculosis IgM Antibodies	Non-Reactive (Negative)	Reactive (Positive) – Suggests recent or active Tuberculosis infection.
Internal Procedural Control Line	Visible Control Line Present	Absent Control Line – Indicates an invalid test run; requires immediate retesting.
Serum Appearance (Physical Integrity)	Clear, Straw-Colored	Hemolyzed, Lipemic, or Icteric – May require a fresh sample draw to ensure accuracy.
Clinical Correlation Requirement	No active infection detected	Reactive markers present – Requires immediate clinical correlation and specialist referral.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Hep B,C & ICT TB?

• Experienced Healthcare Professionals: Dr. Essa Lab is staffed by highly qualified, board-certified pathologists, microbiologists, and technologists who oversee all testing procedures.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and confidentiality at every stage of the diagnostic journey.
• Quality Diagnostic Services: Utilizing state-of-the-art diagnostic equipment and adhering to stringent internal and external quality control protocols.
• Professional Reporting: Reports are clear, comprehensive, and structured to provide maximum clinical utility for your treating physician.
• Modern Diagnostic Approach: Dr. Essa Lab continuously updates its testing methodologies to align with the latest international guidelines and technological advancements.
• Comfortable Environment: All collection centers are designed to provide a clean, hygienic, and welcoming environment for patients of all ages.
• Convenient Locations: With an extensive network of branches across Karachi and Sindh, finding a Dr. Essa Lab collection point near you is simple and convenient.
• Commitment to Accurate Diagnosis: Since 1987, Dr. Essa Lab has built a reputation of trust and accuracy, making it one of the most respected diagnostic names in Pakistan.